Skip to content

Clinical trials

Phase 3 Disorders of Excessive Somnolence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disorders of Excessive Somnolence Phase: Phase 3 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20048
20051
20081
20093
20102
20113
20121
20131
20163
20201
20212
20222
20231
20242
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting8
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bioprojet10
Cephalon10
Axsome Therapeutics, Inc.4
Alkermes, Inc.3
Harmony Biosciences Management, Inc.3
Avadel2
Citrine Medicine Limited1
Dr. Rajendra Prasad Government Medical College1
Eileen R. Chasens1
Ignis Therapeutics (Suzhou) Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disorders of Excessive Somnolence40
Narcolepsy18
Cataplexy14
Sleep Apnea, Obstructive12
Sleep Wake Disorders9
Sleep Disorders, Circadian Rhythm4
Chronobiology Disorders3
Sleepiness3
Fatigue2
Idiopathic Hypersomnia2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.